Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?

Judith van Loon; Janneke P. C. Grutters; Fergus Macbeth

doi:10.1016/S1470-2045(11)70379-5

Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?

Judith van Loon^*, Janneke P. C. Grutters, Fergus Macbeth

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

46 Citations (Web of Science)

Original language	English
Pages (from-to)	E169-E177
Journal	Lancet oncology
Volume	13
Issue number	4
DOIs	https://doi.org/10.1016/S1470-2045(11)70379-5
Publication status	Published - Apr 2012

Access to Document

10.1016/S1470-2045(11)70379-5

Cite this

@article{bd63ef95c7e24f758eb52f5e3c2ae14f,

title = "Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?",

author = "{van Loon}, Judith and Grutters, {Janneke P. C.} and Fergus Macbeth",

year = "2012",

month = apr,

doi = "10.1016/S1470-2045(11)70379-5",

language = "English",

volume = "13",

pages = "E169--E177",

journal = "Lancet oncology",

issn = "1470-2045",